If you were handing out the funding, assuming equally good teams, do you choose the work that targets Parkinson’s mechanisms or the functional map of a less-explored bit of CNS?
We are doing basic exploration as well. We are just prioritizing targeted work in a resource constrained environment.
I don't think the issue is about resources per se. I think it's more about Universities prioritizing high impact research, as in, the kind of research that appeals to non-scientists, in industry, media, or academia in general.
Thus either neurology is way more mature than I'm aware of (a real possibility, I'm far from knowledgeable on it) or we do have a problem.
We do know a LOT about neuroscience, but we've no idea how much we've yet to discover. Likely, it's a fractal, so we're not anywhere close and never will be. Like in Physics, we know a LOT about electrons and how to build a bridge, but we know nothing about 'dark energy'. It's also true in neuroscience that we know a LOT about action potentials but nearly nothing about how astrocytes interact with synapses. It's not a smooth march, but a VERY spasmatic stumble.
I don't think fields should progress in any manner whatsoever. They progress as they do and at their own paces. Otherwise it wouldn't be research, it'd be following plans. It's not something that can be proscribed, but more described.
[0]Total anecdata, I have no source for this.
I've had opportunities to review papers from people I have co-authored with before and declined the opportunity. I've reviewed a paper, then got an invitation from another journal to review the same paper. I declined, but sent the editor my former review. I thing there are strong social mores in the scientific community.